BioSpace News Archive

Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted final approval of its Abbreviated New Drug Application for Miglustat Capsules (generic for Zavesca®), 100mg strength.

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Frontiers in Neurology has published results from an investigator-initiated trial, SAVIOR-1, a prospective, randomized, controlled study evaluating non-invasive vagus nerve stimulation (nVNS) using gammaCore Sapphire™ in patients admitted to the hospital for treatment of COVID-19.

BetterLife Pharma Inc. announced that an abstract on the preclinical data on anti-depressant activity of its lead compound 2-bromo-LSD was accepted for presentation at the upcoming Canadian Association for Neuroscience Conference, being held May 12-15 in Toronto, Canada.

Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a comprehensive portfolio of chimeric antigen receptor (CAR) T cell therapies for solid tumors, today announced the Company presented data at the 2022 Annual Meeting of the American Association for Cancer Research (AACR), held at the Ernest N. Morial Convention Center in New Orleans, Louisiana through April 8-13, 2022.

Spero Therapeutics, Inc. announced two oral presentations and four poster presentations at the 32nd European Congress of Clinical Microbiology and Infectious Diseases being held April 23-26, 2022, in Lisbon, Portugal.

Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the successful completion of the first surgery integrating its Remi™ Robotic Navigation, LineSider® Spinal System, and FlareHawk® Expandable Interbody Fusion Device systems in one procedure.

Enzyvant announced plans to develop a Good Manufacturing Practice -compliant regenerative medicine manufacturing facility in Morrisville, NC, part of the Research Triangle Park area.

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced the appointment of Philippe Goix as Chief Commercial Officer for Todos Medical’s wholly-owned CLIA/CAP certified lab, Provista Diagnostics.

The U.S. Food and Drug Administration (FDA) has awarded 510(k) clearance to the Versi™PD Cycler System*, a next generation portable automated peritoneal dialysis (APD) system from Fresenius Medical Care North America (FMCNA).

The American Liver Foundation and Hepatitis B Foundation will join forces with key stakeholders concerned with identifying and addressing the unmet needs of people living with hepatitis D virus.